Cargando…
Abnormal Cystic Tumor in a Patient with Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: Evidence of a Precursor Lesion?
The hereditary leiomyomatosis and renal cell cancer (HLRCC) association is a rare syndrome caused by mutation of the Kreb's cycle enzyme, fumarate hydratase (FH). It is characterized by unusually aggressive type 2 papillary renal cell histology. FH is responsible for catalyzing the conversion o...
Autores principales: | Ristau, Benjamin T., Kamat, Sonal N., Tarin, Tatum V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561951/ https://www.ncbi.nlm.nih.gov/pubmed/26380143 http://dx.doi.org/10.1155/2015/303872 |
Ejemplares similares
-
Hereditary leiomyomatosis and renal cell carcinoma
por: Schmidt, Laura S, et al.
Publicado: (2014) -
Hereditary Leiomyomatosis and Renal Cell Cancer
por: HANSEN, Anders Würgler, et al.
Publicado: (2020) -
Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids
por: Bortoletto, Pietro, et al.
Publicado: (2017) -
Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
por: Chaucer, Benjamin, et al.
Publicado: (2018) -
A Non-Hereditary Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome
por: Kapila, Vaishali, et al.
Publicado: (2021)